Soluble egg antigen of Schistosoma Haematobium induces HCV replication in PBMC from patients with chronic HCV infection

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  El Awady, Mostafa K ^a   Youssef, Samar S ^a   Omran, Moataza H ^a   Tabll, Ashraf A ^a   El Garf, Wael T ^a   Salem, Ahmed M ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b Ain Shams University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PARASITE ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL PROLIFERATION; CELL STIMULATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA CONTENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; MONONUCLEAR CELL; MORBIDITY; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SUPERINFECTION; VIRUS LOAD; VIRUS REPLICATION; WORM EGG;

ADULT; ANIMALS; ANTIGENS, HELMINTH; CELL GROWTH PROCESSES; EGG PROTEINS; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; VIRAL LOAD; VIRUS REPLICATION;

EID: 33747605039     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-91     Document Type: Article

References (37)

1. Kamel MA, Ghaffar YA, Yasef MA, Wright M, Clark LC, Miller F: High HCV prevalence in Egyptian blood donors. Lancet 1992, 340:427.
2. Darwish MA, Raouf TA, Rushdy P, Constantine N, Rao MR, Edelman R: Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993, 49:440-447.
3. Waked IA, Saleh SM, Moustafa MS, Raouf AA, Thomas DL, Strickland GT: High prevalence of hepatitis C in Egyptian patients with chronic liver disease. Gut 1995, 37:105-107.
4. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Ohn ESA, Anwar W, Sallam I: The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355:887-891.
5. WHO: Spread of hepatitis C linked to unsafe injection practices in Egypt. Bulletin of the world health organization 2000, 78(4):562.
6. Saeed A, Al-Admawi AM, Al-Rasheed A, Fairclough D, Bacchus R: Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet 1991, 338:459-460.
7. El-Ahmady O, Halim A-B, Mansour O, Salman T: Incidence of hepatitis C virus in Egyptians. J Hepatol 1994, 21:687.
8. Badawi AF, Michael MS: Risk factors for hepatocellular carcinoma in Egypt: the role of hepatitis-B viral infection and schistosomiasis. Anticancer Res 1999, 19:4565-9.
9. Aquino RT, Chieffi PP, Catunda SM, et al: Hepatitis B and C virus markers among patients with hepatosplenic mansonic schistosomiasis. Rev Inst Med Trop Sao Paulo 2000, 42:313-20.
10. Kamal SM, Graham CS, He Q, Bianchi L, Tawil AA, Rasenack JW, Khalifa KA, Massoud MM, Koziel MJ: Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis 2004, 1;189(7):1140-50.
11. El Ridi R, Ismail S, Gaafar T, El Demellawy M: Differential responsiveness of humans with early-stage schistosomiasis haematobium to Schistosoma haematobium soluble adult-worm and egg antigens. Parasitol Res 1997, 83(5):471-7.
12. Freedman DO, Ottsen EA: Eggs of schistosoma mansoni stimulate endothelial cell proliferation in vitro. Infectious diseases 1989, 158:556.
13. Almeida CA, Leite MF, Goes AM: Signal transduction events in peripheral blood mononuclear cells stimulated by Schistosoma mansoni antigens. Hum Immunol 2001, 62(10):1159-66.
14. El Awady MK, Gad YZ, Wen Y, Essawi M, Effat L, Amr KS, Ismail S, Christ CJ: Schistosoma hematobium soluble egg antigen induces proliferation of urothelial and endothelial cells. World J Urol 2001, 19:263.
15. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-phenol cloroform extraction. Anal Biochem 1987, 162:156.
16. Angelico M, Renganathan E, Gandin C, Fathy M, Profili MC, Refai W, De Santis A, Nagi A, Amin G, Capocaccia L, Callea F, Rapicetta M, Badr G, Rocchi G: Chronic liver disease in the Alexandria governorate, Egypt: combination of Schistosomiasis and virus infections. J hepatol 1997, 26:236.
17. Halim AB, Garry RF, Dash S, Gribier MA: Effect of schistosomiasis and hepatitis on liver disease. Am J Trop Med Hyg 1999, 60(6):915.
18. Zaki A, Bassili A, Amin G, Aref T, Kandil M, Abou Basha LM: Morbidity of schistosomiasis mansoni in rural Alexandria, Egypt. J Egypt Soc Parasitol 2003, 33(3):695-710.
19. Buratti E, Tisminetzky S, Zotti M, Baralle FE: Functional analysis of the interaction between HCV 5′ UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Research 1998, 26(13):3179-3187.
20. Fukushi S, Okada M, Stahli J, Kageyama T, Hoshino FB, Kazuhiko Katayama: Ribosomal Protein S5 Interacts with the Internal Ribosomal Entry Site of Hepatitis C Virus. The J of Biological Chemistry 2001, 276(24):20824-20826. Issue of June 15
21. Gontarek RR, Gutshall LL, Herold KM, Tsai J, Sathe GM, Mao J, Prescott G, Del Vecchio AM: hnRNPC and polypyrimidine tract-binding protein specifically interact with the pyrimidine-rich region with the 3′ NTR of the HCV genome. Nucleic Acids Research 1999, 27(6):1457.
22. Krecic AM, Swanson MS: hnRNP complexes: composition, structure and function. Curr Opin Cell Biol 1999, 363:71.
23. Kamal S, Madwar M, Bianchi L, Tawil AE, Fawzy R, Peters T, Rasenack JW: Clinical, virological and histopathological features: long-term follow-up in patients with chronic hepatitis C coinfected with S. mansoni. Liver 2000, 20(4):281-9.
24. Kamal S, Bianchi L, Al Tawil A, Koziel M, El Sayed Khalifa K, Peter T, Rasenack JW: Specific cellular immune response and cytokine patterns in patients coinfected with hepatitis C virus and Schistosoma mansoni. J Infect Dis 2001, 15;184(8):972-82.
25. Pham TN, Macparland SA, Coffin CS, Lee SS, Bursey FR, Michalak TI: Mitogen-induced upregulation of hepatitis C virus expression in human lymphoid cells. J Gen Virol 2005, 86(Pt 3):657-66.
26. Kuruda H, Yasunaga Y, Takatera H, Fujioka H, Ohnishi A, Tsujimoyo M: growth factors of bladder cancer determined by proliferating cell nuclear antigen immunostaining. Hinyokika Kiyo 1994, 40(5):379-82.
27. Wada. T, Shimabukuro T, Kurisu H, Shameam IA, Yashihiro S, Matsuyama H, Naito K, Hashimoto O, Tanaka K: Expression of proliferation cell nuclear antigen in superficial bladder cancer-application to paraffin-embeded tissue sections. Hinyokika Kiyo 1993, 39:313-319.
28. Gaafar T, Ismail S, Helmy M, Afifi A, Guirguis N, el Ridi R: Identification of Schistosoma haematobium soluble egg antigens that elicit human granuloma formation in vitro. Parasitol Res 1993, 79(2):103-8.
29. Loeffler DA, Lundy SK, Singh KP, Gerard HC, Hudson AP, Boros DL: Soluble egg antigens from Schistosoma mansoni induce angiogenesis-related processes by up-regulating vascular endothelial growth factor in human endothelial cells. J Infect Dis 2002, 1;185(11):1650-6.
30. Imura S, Miyake H, Izumi K, Tashiro S, Uehara H: Correlation of vascular endothelial cell proliferation with microvessell density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma. J Med Invest 2004, 51(3-4):202-9.
31. Muller HM, Pfaff E, Goeser T, kallinowski B, Salbach C, Theilmann L: Peripheral blood leukocytes serve as possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993, 74:669.
32. Laskus T, Radkowski M, Piasek A, Nowicki M, Horban A, Cianciara J, Rakcla J: Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type I: evidence of active replication in monocyte/macrophages and lymphocytes. J Infect Dis 2000, 181:442.
33. El Awady MK, Abdel Rahman MM, Ismail SM, Amr KS, Omran M, Mohamed SA: Prediction of relapse after interferon therapy in hepatitis C virus infected by the use of triple assay. Journal of Gastroenterology and Hepatology 2002, 18:68.
34. EL-Awady MK, Tabll A, Redwan E, Youssef SS, Omran MH, Thakeb F, El-Demellawy M: Flow Cytometric Detection of Hepatitis C Virus Antigens In Infected Peripheral Blood Leukocytes: Binding and Entry. world. J Gastroenterol 2005, 11(33):5203-5208.
35. Sansonno D, Lacobelli AR, Cornachiulo V, Iodice G. Dammacco F: Detection of HCV proteins by immunofluoresence and HCV RNA genomic sequences by non-isotopic in situ hybridization in bone marrow cells and PBMC of chronically HCV infected patients. Clin Exp Immunol 1996, 103:414-21.
36. Gong GZ, Lai LY, Jiang YF, He Y, Su XS: HCV replication in PBMC and its influence on interferon therapy. World J Gastroenterol 2003, 9(2):291.
37. Ishii A, Matsuoka H, Aji T, Hayatsu H, Wataya Y, Arimoto S, Tokuda H: Evaluation of the mutagenicity and the tumor-promoting activity of parasite extracts: Schistosoma japonicum and Clonorchis sinensis. Mutat Res 1989, 224(2):229-33.